Prospect of a prophylactic vaccine for HIV

British Medical Bulletin

Volumn 58, Issue , 2001, Pages 205-218

  Hanke, T ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; ANTIBODY RESPONSE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; INFECTION CONTROL; INFECTION PREVENTION; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; VIRUS GENOME; VIRUS INACTIVATION;

AIDS VACCINES; ANIMALS; CLINICAL TRIALS; DRUG DESIGN; FORECASTING; HIV INFECTIONS; HIV-1; HUMANS; MODELS, ANIMAL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0035165094     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/bmb/58.1.205     Document Type: Review

References (41)

1. AIDS as a zoonosis: Scientific and health implications
2. HIV gp120: Double lock strategy foils host defences
3. T cell responses and viral escape
4. Immune responses in HIV-exposed seronegatives: Have they repelled the virus?
5. Late seroconversion in HIV 'resistant' Nairobi prostitutes is associated with a preceding decrease in HIV exposure
6. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
7. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
8. Control of SHIV-89.6P infection of cynomologus monkeys by HIV-1 Tat protein vaccine
9. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
10. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
11. Anti-HIV cellular immunity: Recent advances towards vaccine design
12. Recombinant subunit vaccines against primate lentiviruses
13. AIDS preclinical vaccine development: Biennial survey of HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates
14. Live attenuated HIV vaccines: A proposal for further research and development
15. Live attenuated AIDS viruses as vaccines: Promise or peril?
16. Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence
17. Immunologic and virologic status after 14 and 18 years of infection with an attenuated strain of HIV-1: A report from the Sydney Blood Bank Cohort
18. Vehicles for genetic vaccines against human immunodeficiency virus: Induction of T cell-mediated immune responses
19. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination
20. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime
21. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
22. Vaccination with Rev and Tat against AIDS
23. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
24. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen
25. Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya
26. Why do we not have an HIV vaccine and how can we make one?
27. Antibody neutralization of HIV-1 and the potential for vaccine design
28. Immunological and immunological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines
29. HIV-1 neutralizing antibodies: How full is the bottle?
30. + T cells in HIV infection
31. Role for cytotoxic T lymphocytes in protection against HIV infection and AIDS
32. Immune control of HIV-1 after early treatment of acute infection
33. AIDS. Escape from the immune system
34. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viremia
35. + lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi
36. + nef-specific cytotoxic T cells in vaccinated animals
37. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: Effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara
38. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge
39. High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection
40. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV